These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3427262)
1. Experimental studies on pathogenesis and progression of uremic neuropathy in rats. II. Is plasma myoinositol a uremic neurotoxin? Onishi S; Kawasaki T; Hamada K Bull Osaka Med Sch; 1986 Oct; 32(2):66-72. PubMed ID: 3427262 [No Abstract] [Full Text] [Related]
2. Experimental studies on pathogenesis and progression of uremic neuropathy in rats. I. Development of chronic renal failure in rats. Onishi S; Okada S; Takasaki N Bull Osaka Med Sch; 1986 Oct; 32(2):60-5. PubMed ID: 3427261 [No Abstract] [Full Text] [Related]
7. Raised plasma-myoinositol levels in uraemia and experimental neuropathy. Clements RS; DeJesus PV; Winegrad AI Lancet; 1973 May; 1(7813):1137-41. PubMed ID: 4123536 [No Abstract] [Full Text] [Related]
8. [Uremic polyneuropathy. Case studies]. Fierro B; Fradà G; Li Vecchi M; Raimondo D Arch Sci Med (Torino); 1981; 138(4):609-14. PubMed ID: 7340740 [No Abstract] [Full Text] [Related]
9. Relationship between plasma concentration of middle molecular weight fraction b, motor nerve conduction velocity, and plasma creatinine in experimental chronic renal failure rats. Boudet J; Man NK; Cueille G; Legrain Y; Funck-Brentano JL Artif Organs; 1981; 4 Suppl():115-8. PubMed ID: 7295077 [No Abstract] [Full Text] [Related]
10. Neurotoxicity of parathyroid hormone in uremia. Massry SG Kidney Int Suppl; 1985 Dec; 17():S5-11. PubMed ID: 3912589 [No Abstract] [Full Text] [Related]
11. [Study of nerve conduction velocity in uremic neuropathy]. Parisen Toldin P; Pisani E; D'Andrea G; Lagreca G; Ferro Milone F Riv Neurobiol; 1976; 22(1-2):45-6. PubMed ID: 1052935 [No Abstract] [Full Text] [Related]
12. Uremic neuropathy: clinical features and new pathophysiological insights. Krishnan AV; Kiernan MC Muscle Nerve; 2007 Mar; 35(3):273-90. PubMed ID: 17195171 [TBL] [Abstract][Full Text] [Related]
13. [Relationship between serum myo-inositol and peripheral neuropathy in patients with chronic renal failure]. Kuzuhara K; Kaniu H; Tsuji H; Furukawa K; Miura M; Hara S; Suzuki Y; Nihei H; Akagi K; Uchigata M Nihon Jinzo Gakkai Shi; 1986 Jun; 28(6):739-47. PubMed ID: 3022045 [No Abstract] [Full Text] [Related]
14. [Influence of erythropoietin produced in vitro on experimental uremic anemia]. Hu R Zhonghua Yi Xue Za Zhi; 1990 Sep; 70(9):522-4. PubMed ID: 1964859 [No Abstract] [Full Text] [Related]
15. Does uremic enterocolitis exist? A morphological and functional investigation of rat intestine in chronic renal insufficiency. Gabbert H; Wagner R; Höhn P; Kern O; Wanitschke R Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 37(3):285-96. PubMed ID: 6117973 [TBL] [Abstract][Full Text] [Related]
16. [Uremic neuropathies. Comparative study of the velocity of motor and nerve conduction during predialysis, hemodialysis and postransplantation periods]. Fernández González F Arch Neurobiol (Madr); 1976; 39(1):15-36. PubMed ID: 776116 [No Abstract] [Full Text] [Related]
17. Uremic neuropathy. Monitoring of transketolase activity inhibition in a child. McVicar M; Gauthier B; Goodman CT Am J Dis Child; 1973 Feb; 125(2):263-5. PubMed ID: 4265477 [No Abstract] [Full Text] [Related]
18. Experimental uremic neuropathy. Part 1. Decreased nerve conduction velocity in rats. Tegnèr R; Brismar T J Neurol Sci; 1984 Jul; 65(1):29-36. PubMed ID: 6470744 [TBL] [Abstract][Full Text] [Related]
19. Comparison of motor and sensory nerve conduction velocity in early uremic polyneuropathy. Jebsen RH; Tenckhoff H Arch Phys Med Rehabil; 1969 Mar; 50(3):124-6. PubMed ID: 4304421 [No Abstract] [Full Text] [Related]
20. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. Lebel M; Rodrigue ME; Agharazii M; Larivière R Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]